Who is sponsoring NCT06096662?

NCT06096662 is sponsored by Vastra Gotaland Region.

What drugs are being tested in NCT06096662?

Interventions in NCT06096662: Verb Network Strenghtening Treatment (VNeST).

What condition does NCT06096662 study?

NCT06096662 studies Aphasia, Anomia, Stroke.

Is NCT06096662 still recruiting?

NCT06096662 is currently completed. Last updated 12 June 2025.

Last reviewed 2025-06-12 · How we verify

NCT06096662

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Verb Network Strengthening Treatment (VNeST) Via Telerehabilitation on Word Finding in Post-stroke Aphasia.

Completed NA Last updated 12 June 2025

What this trial tests

NA trial testing Verb Network Strenghtening Treatment (VNeST) in Aphasia in 10 participants. Completed in 9 July 2024.

Timeline

1 November 2023

Primary endpoint
9 July 2024

9 July 2024

Quick facts

Lead sponsor	Vastra Gotaland Region
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	10
Start date	1 November 2023
Primary completion	9 July 2024
Estimated completion	9 July 2024
Sites	1 location across Sweden

Drugs / interventions tested

Verb Network Strenghtening Treatment (VNeST)

Conditions studied

Aphasia — all drugs for Aphasia →
Anomia — all drugs for Anomia →
Stroke — all drugs for Stroke →

Sponsor

Vastra Gotaland Region — full company profile →

Who can join

Adults 18 to 99, any sex, with Aphasia or Anomia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite evidence showing that speech and language intervention may improve language and communication abilities in people with acquired language disorders (aphasia), there is still need for evidence for which types of therapy are effective. Further, to improve accessibility of care, there is increasing need for evidence of intervention effects when therapy is provided online, via telerehabilitation. Therefore, the project aims at evaluating the effects of telerehabilitation with a specific speech-language therapy intervention for improving word-finding in individuals with aphasia due to stroke. The intervention Verb Network Strengthening Treatment (VNeST) trains word finding at sentence level, and the treatment effect is expected to generalize to the production of connected speech.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aphasia

Currently open trials in the same condition.

NCT07460037 — Chinese-Specific Speech Imagery Coding Using High-Density ECoG · NA · recruiting
NCT07397923 — Exploratory Evaluation of the Digital Therapeutic Device Zenicom for Subacute Stroke Aphasia · Phase 2 · recruiting
NCT07281313 — Aphasia Physical EXercise Study: Randomized Trial · NA · recruiting
NCT06990997 — Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia · NA · recruiting
NCT06974279 — Post-Stroke Aphasia TMS · NA · recruiting

Other Vastra Gotaland Region trials

Trials by the same sponsor.

NCT07430865 — The RECOVER Study - Postpartum Recovery of Pelvic Floor Structures and the Impact of Early Rehabilitation · NA · recruiting
NCT07472335 — Home-based Acute Care for Older Persons Initiated by the Emergency Medical and Ambulance Services - a Retrospective Obse · not yet recruiting
NCT07246577 — The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant C · recruiting
NCT07449338 — Prospective Cohort Study of Response and Tolerability of Accelerated Intermittent Theta-burst Stimulation (1W-AiTBS) · not yet recruiting
NCT07334340 — Modified vs Standard CDED: Evaluation of a Nordic Adaptation of Nutritional Therapy in Paediatric Crohn's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06096662 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vastra Gotaland Region
Last refreshed: 12 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06096662.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing